SHANGHAI JUNSHI BIO YC1 (8SJ) — Cash Flow-to-Debt Ratio
Latest as of December 2025:
-0.08x
SHANGHAI JUNSHI BIO YC1 (8SJ) has a Cash Flow-to-Debt Ratio of -0.08x as of December 2025, meaning its operating cash flow of €-514.51 Million could theoretically repay 0% of its total liabilities (€6.33 Billion) in one year. See 8SJ financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.08x
Operating CF / Total Liabilities
Operating Cash Flow
€-514.51 Million
EUR
Total Liabilities
€6.33 Billion
EUR
Data as of
Dec 2025
Most recent filing
SHANGHAI JUNSHI BIO YC1 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for SHANGHAI JUNSHI BIO YC1 across 5 annual periods. For the full cash flow conversion analysis, see SHANGHAI JUNSHI BIO YC1 cash flow conversion.
Annual Cash Flow-to-Debt Ratio for SHANGHAI JUNSHI BIO YC1 (2021–2025)
Year-by-year debt coverage analysis for SHANGHAI JUNSHI BIO YC1.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.08x | €-514.51 Million | €6.33 Billion | ▲ +72.7% |
| 2024 | -0.30x | €-1.44 Billion | €4.85 Billion | ▲ +40.6% |
| 2023 | -0.50x | €-2.01 Billion | €4.02 Billion | ▲ +21.5% |
| 2022 | -0.64x | €-1.78 Billion | €2.78 Billion | ▼ -170.3% |
| 2021 | -0.24x | €-641.90 Million | €2.72 Billion | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.